The World Chemistry Congress has been successfully organized 2 times in Osaka, Japan in previous years. The 3rd World Chemistry Congress 2025 (IWCC-2025) will be held from May 12-14, 2025 in Kobe, Japan. It is committed to building a global cooperation platform for communication among scientists, research institutions and enterprises engaged in Chemistry fields around the world, and promoting the development of international communication.
● One Plenary Forum Addresses by a Panel of Prominent Leaders from all over the world
● 20+ High Profile Breakout Sessions across 3-Days Conference
● 100+ Oral Presentations Covering Hot Topics and Cutting-Edge Technology
● 200+ Attendees from Across the Globe for Unrivalled Network in Building up a High-end International Conference Brand, Promoting Scientific Exchanges, Cooperative Development, and Establishing a Marketing platform
● 2 Joint Satellite Clustering Meetings of IDDST and SDDS
● Tech Tour to Famous Spots

Dr. Matthias von Herrath,
Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA

Dr. Bhanu P. Jena,
George E. Palade University Professor & Distinguished Professor, Wayne State University School of Medicine, USA

Dr. Yongmin Zhang,
First-Class Research Director, French National Centre for Scientific Research, IPCM - UMR 8232, Sorbonne University, France

Dr. Boris Gorelik,
MOBIChem Scientific Engineering Ltd., Israel

Dr. Stefan J. Scherer,
CEO and President, 3T Biosciences, USA
Ms. Chrissie Fletcher,
Vice President of Biostatistics, GSK, UK
Dr. Paul A. Insel,
Distinguished Professor of Pharmacology and Medicine, Co-Director, Medical Scientist (MD/PhD) Training Program, University of California San Diego, USA
Dr. Megan Gibbs,
Vice President, Global Head of Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, USA
Dr. Rainer Ganschow,
Director, Department of Pediatrics, University Children's Hospital Bonn, Germany

Dr. Nabil Hagag,
Director of Cellular Therapies, Stony Brook Medicine, USA

Dr. Ottavio Arancio,
Professor, Columbia University, USA
Dr. Yaguang Xi,
Professor, University of Georgia, USA
Dr. Weiwei Dang,
Associate Professor, Baylor College of Medicine, USA
Dr. Liju Yang,
Professor, North Carolina Central University, USA
Dr. Maria Vitoria Lopes Badra Bentley,
Professor, University of Sao Paulo, Brazil

Dr. Wai Hong (Kevin) Lo,
Associate Professor, University of Connecticut Health Center, USA

Dr. Avigdor Scherz,
Professor, Weizmann Institute of Science, Israel
Dr. Hsing-Yu Tuan,
Professor, National Tsing Hua University, Taiwan
Dr. William Hogan,
Associate Professor of Medicine, Mayo Clinic, USA
Dr. Abul K Fazlur Rahman,
Professor and Chair, The University of Oklahoma, USA
Dr. Catherine CL Wong,
Professor, Peking Union Medical College Hospital, Chinese Academy of Medical Science, China

Dr. Matthias von Herrath
Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA

Dr. Diane J. Burgess
Distinguished Professor and Pfizer Distinguished Chair of Pharmaceutical Technology, University of Connecticut, USA
Dr. Jeff Song
Vice President, Boehringer Ingelheim Pharmaceuticals, Inc, USA
Dr. Muneto Mogi
Global Head, Global Discovery Chemistry, Novartis Institutes for BioMedical Research (NIBR), USA
Dr. Anne S.J. Lesage
Chief Early Development Officer, Pharvaris GmbH, Switzerland
Dr. Antonio Cabal
Sr. Director, Biology Based Modeling & Simulation, Eisai Inc., USA

Dr. Lloyd Friedman
Professor, Yale University School of Medicine, USA

Dr. Mats Larsson
Professor, Department of Physics, Stockholm University, Sweden

Dr. Lili Zhang,
Senior Scientist & Division Director, A*STAR, Singapore

Dr. Hans Keirstead,
Chief Executive Officer, AIVITA Biomedical, Inc., USA

Dr. Farzin Farzaneh,
Chief Scientific Officer, Virocell Biologics Limited;
Professor of Molecular Medicine, King’s College London, UK

Dr. Nan Yao,
Professor and Director, Princeton University, USA

Dr. David D. Thomas,
William F. Dietrich Professor, University of Minnesota, USA

Dr. George Udeani,
Professor and Head, Texas A&M University, USA

Dr. Bradly Keck,
Director, Pharmaron, USA

Dr. Richard Denk,
Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland

Dr. Kiyoshi Nokihara,
Founder CEO & CSO, HiPep Laboratories, Japan

Dr. Dulcie A Mulholland,
Professor, Department of Chemistry, University of Surrey, UK

Dr. Michael Junger,
Head of Medical Device, Vaxxas Nanopatch, Australia

Dr. Suzanne Giasson,
Full Professor, Universite de Montreal, Canada

Dr. Boris V. Nemzer,
Vice President of Research and Development, VDF FutureCeuticals, Inc, USA

Dr. Molly Wang,
Professor, Chemistry and Biochemistry Department, Kent State University, USA

Dr. Abul K Fazlur Rahman,
Professor and Chair, The University of Oklahoma, USA

Dr. Yuhua Li,
Co-Founder, Sr. Vice President of R & D, Foresee Pharmaceuticals USA, Inc., USA

Dr. Nathalie Wauthoz,
Professor, Universite Libre de Bruxelles, Belgium

Dr. Frank Fan,
Head of Biology, Promega Corporation, USA
IWCC2025 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth
● To Meet Face-to-Face with the International Movers and Shakers
● To Meet with Key Decision Marker
● To Explore Business Opportunities
● To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
● To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall
Exhibition Date:
1.Set-up date: May 11, 2025
Show dates: May 12-14, 2024
Place: Kobe, Japan
Kobe is the capital of Hyogo Prefecture and one of Japan's ten largest cities. Located between the sea and the Rokko mountain range, Kobe is also considered one of Japan's most attractive cities. Its neighbouring city Osaka, and nearby Kyoto are the centres of the Keihanshin Industrial Zone, the second largest urban and industrial agglomeration in Japan, and the city and its surroundings constitute the western portion of the Osaka-Kobe metropolitan area.